ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy).

Emanuele Monda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.